Article
Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA.
Communications biology - 22 Oct 2020
Varela Maria Celeste, Roch Melanie, Taglialegna Agustina, Long Scott W, Saavedra Matthew Ojeda, Rose Warren E, Davis James J, Hoffman Lucas R, Hernandez Rafael E, Rosato Roberto R, Rosato Adriana E
Abstract excerpt
Chronic airways infection with methicillin-resistant Staphylococcus aureus (MRSA) is associated with worse respiratory disease cystic fibrosis (CF) patients. Ceftaroline is a cephalosporin that inhibits the penicillin-binding protein (PBP2a) uniquely produced by MRSA. We analyzed 335 S. aureus isolates from CF sputum samples collected at three US centers between 2015-2018. Molecular relationships demonstrated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
